The number of traffic fatalities either remained stable or decreased in the three years following legalisation.
Five years on the country has seen ‘major societal benefits’ but the public health effects remain a 'mixed picture'.
Your bi-weekly round-up of the latest cannabis news
The bill to legalise medical cannabis will now advance to its second reading in parliament.
Members are expected to call for the liberalisation of drug policy, but what form this will take remains to be seen.
Your round-up of the latest cannabis news
Research suggests that non-profit associations play a key role in future legislation reform and in achieving social equity post-prohibition.
Reports suggest the Macron government will not support general legalisation when the medical cannabis experiment ends in 2024.
Following a number of delays, officials have now confirmed that the startup phase will begin on 15 December.
The US Department of Health and Human Services has recommended that cannabis be classed as a lower risk drug. What does this mean for research, industry...
